Heartland Advisors’s AngioDynamics ANGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-287,192
Closed -$2.43M 176
2023
Q4
$2.43M Sell
287,192
-103,692
-27% -$719K 0.13% 160
2023
Q3
$3.15M Sell
390,884
-78,846
-17% -$656K 0.18% 156
2023
Q2
$4.9M Sell
469,730
-155,986
-25% -$1.5M 0.28% 130
2023
Q1
$6.47M Buy
625,716
+13,994
+2% +$179K 0.4% 113
2022
Q4
$8.42M Buy
611,722
+175,383
+40% +$2.44M 0.53% 86
2022
Q3
$8.93M Buy
436,339
+118,440
+37% +$2.6M 0.67% 60
2022
Q2
$6.15M Buy
317,899
+30,500
+11% +$625K 0.43% 105
2022
Q1
$6.19M Sell
287,399
-10,053
-3% -$228K 0.38% 116
2021
Q4
$8.2M Hold
297,452
0.48% 98
2021
Q3
$7.72M Hold
297,452
0.47% 96
2021
Q2
$8.07M Sell
297,452
-38,897
-12% -$950K 0.47% 91
2021
Q1
$7.87M Sell
336,349
-7,019
-2% -$142K 0.5% 83
2020
Q4
$5.26M Buy
343,368
+212,252
+162% +$2.69M 0.38% 112
2020
Q3
$1.58M Sell
131,116
-476,316
-78% -$4.52M 0.14% 178
2020
Q2
$6.18M Sell
607,432
-100,780
-14% -$1.04M 0.55% 77
2020
Q1
$7.39M Buy
708,212
+286,132
+68% +$3.59M 0.79% 42
2019
Q4
$6.76M Buy
422,080
+57,611
+16% +$880K 0.5% 94
2019
Q3
$6.71M Buy
364,469
+40,040
+12% +$783K 0.51% 88
2019
Q2
$6.39M Sell
324,429
-323
-0.1% -$6.58K 0.47% 102
2019
Q1
$7.42M Sell
324,752
-131,294
-29% -$2.85M 0.55% 81
2018
Q4
$9.18M Sell
456,046
-47,781
-9% -$989K 0.76% 47
2018
Q3
$11M Buy
503,827
+146,498
+41% +$3.25M 0.73% 53
2018
Q2
$7.95M Buy
357,329
+10,080
+3% +$206K 0.52% 88
2018
Q1
$5.99M Buy
+347,249
New +$5.79M 0.4% 113

Other funds holding ANGO

Heartland Advisors's ANGO Position: Q1 2024 in Review

Heartland Advisors sold out of AngioDynamics (ANGO) in Q1 2024, closing a stake of 287,192 shares — an estimated $2.43M sold.

Heartland Advisors first reported a position in ANGO in Q1 2018 and held it in 24 quarters. The position peaked at $11M in Q3 2018. 135 funds tracked by Wall St. Rank hold ANGO as of Q1 2024.

  • Heartland Advisors reported no remaining AngioDynamics position as of Q1 2024 after selling out during the quarter.
  • Heartland Advisors sold 287,192 AngioDynamics shares in Q1 2024, an estimated $2.43M.
  • Heartland Advisors first reported a position in AngioDynamics in Q1 2018 and held it in 24 quarters.
  • Heartland Advisors's AngioDynamics position peaked at $11M in Q3 2018.
  • 135 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2024.

Based on Heartland Advisors's 13F filing for Q1 2024, filed 7 May 2024.